SUMMIT SECURITIES GROUP LLC
Broker-DealerPosition in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1531593
NEW YORK, NY
Position in AUPH
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$17,224
New position
Shares Held
1,015
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#229
of 279 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUMMIT SECURITIES GROUP LLC holds $2,866,317 across 26 Biotechnology names. AUPH ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
14,000 | $1,865,640 | |
| 2 | INSM |
INSMED Inc
|
3,800 | $405,156 | |
| 3 | KYMR |
Kymera Therapeutics, Inc.
|
750 | $86,002 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148 | $79,468 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
971 | $79,146 | |
| 6 | CGON |
CG Oncology, Inc.
|
976 | $69,344 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
543 | $60,289 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
634 | $39,903 |
All Filings in AUPH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,224 | 1,015 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||